ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Kintetsu World Express Obtains IATA CEIV Pharma Certification at Three Major European Gateways

TOKYO, JP / ACCESS Newswire / September 24, 2025 / Kintetsu World Express, Inc. (Tokyo, Japan) is pleased to announce that its European subsidiaries, Kintetsu World Express (Deutschland) GmbH (KWE Germany) and Kintetsu World Express (Benelux) B.V. (KWE Benelux), obtained the IATA CEIV Pharma certification in July 2025 at three airports: Frankfurt (Germany), Amsterdam (Netherlands), and Brussels (Belgium). The International Air Transport Association (IATA) established the Center of Excellence for Independent Validators (CEIV) Pharma program to standardize and elevate the handling of pharmaceutical products in air transport.KWE Benelux Amsterdam Branch

KWE Benelux Amsterdam Branch

These airports serve as key gateways for KWE in Europe. With this certification, the KWE Group further strengthens its ability to support the supply chains of customers in the life science and healthcare sectors with greater safety, reliability, and efficiency.

Transporting life science and healthcare products requires strict temperature control and compliance with national regulations. CEIV Pharma certification encompasses Good Distribution Practice (GDP) standards across countries and serves as an international endorsement by a third party that validates the quality, safety, and regulatory compliance required for air transportation. With this certification, KWE is able to provide end-to-end quality management at an even higher standard.

KWE Benelux is already recognized as a central hub for pharmaceutical logistics in Europe. The company operates a dedicated warehouse with a Wholesale Distribution Authorization (WDA) GDP license, offering temperature-controlled storage at 15-25°C, 2-8°C, and -20°C, and delivers high-quality logistics services through a specialized team that ensures regulatory compliance. This latest certification further reinforces these capabilities.

The KWE Group had previously obtained CEIV Pharma certification in Narita (Japan) and is in the process of pursuing certification at two additional European locations. In addition, the KWE Group has acquired GDP certification at 12 locations across 10 countries, enabling us to provide seamless and consistent life science and healthcare logistics services worldwide while meeting each country's regulatory requirements.

The KWE Group will continue to strengthen its commitment to the healthcare industry, which we have identified as a priority sector in our management plan, and will accelerate the global expansion of services to meet the increasingly sophisticated and diverse needs of pharmaceutical logistics.

Contact Information

Mike Trejo
(310) 627-3129

.

SOURCE: Kintetsu World Express



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.